Overview

Chlorzoxazone in Hip and Knee Arthroplasty

Status:
Completed
Trial end date:
2019-07-31
Target enrollment:
0
Participant gender:
All
Summary
The purpose of this study is to elucidate whether patients operated with THA and TKA can benefit from treatment with chlorzoxazone.
Phase:
Phase 4
Accepts Healthy Volunteers?
No
Details
Lead Sponsor:
Northern Orthopaedic Division, Denmark
Treatments:
Chlorzoxazone
Criteria
Inclusion Criteria:

- Planned primary unilateral THA or TKA

- Patients (male/female) ≥ 18 år

- Patients giving written informed consent and authority.

- Patients receiving spinal anaesthesia

Exclusion Criteria:

- Patients with intolerance to trial medications

- Rejection of or contraindicated spinal anaesthesia

- Patients with rheumatoid arthritis.

- Patients with Body Mass Index (BMI) ≥ 35

- Patients that do not read or write Danish